Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Determining the effect of repetitive transcranial magnetic stimulation on attention deficits in a pediatric population with attention deficit/hyperactivity disorder

FY 2021-22

Summary
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children. When attention difficulties are left untreated, they can result in serious long-term consequences. Stimulant medications are the primary treatment for children with ADHD but they can be ineffective, have undesired side effects, and can carry a social stigma that stops parents from using the treatment. This project will investigate a new potential treatment option for children with ADHD with the goal to improve patient outcomes. Repetitive transcranial magnetic stimulation (rTMS), a safe form of non-invasive brain stimulation, can use magnetic fields in a specific area of the brain to stimulate nerve cells. A brain region called the right superior frontal gyrus (rSFG) has been identified as an area with chemical differences in children with ADHD. We will use rTMS to target the rSFG in children with ADHD and determine if it can improve their attention abilities and if that is related to their chemical changes in the brain. Attention abilities will be determined using behavioural tests. The chemical changes in the brain will be measured using a non-invasive magnetic resonance spectroscopy (MRS) scan. Together, we expect that rTMS will alter the levels of chemicals in the rSFG and will be related to an improvement in attention abilities after the treatment. Children aged 8-15 with ADHD will be asked to participate in treatment for one hour a day, 5 days a week for 4 weeks. The participants will be randomly assigned to an active or placebo group. We hope to show that attention abilities are improved in the group that receives active treatment.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466587
Name
Wiley Bevin
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the effect of repetitive transcranial magnetic stimulation on attention deficits in a pediatric population with attention deficit/hyperactivity disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Attention Deficit Hyperactivity Disorder; Glutamate; Magnetic Resonance Spectroscopy; Mental Health; Neuroimaging; Non-Invasive Brain Stimulation; Pediatrics; Superior Frontal Gyrus; Transcranial Magnetic Stimulation
Abstract
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children. When attention difficulties are left untreated, they can result in serious long-term consequences. Stimulant medications are the primary treatment for children with ADHD but they can be ineffective, have undesired side effects, and can carry a social stigma that stops parents from using the treatment. This project will investigate a new potential treatment option for children with ADHD with the goal to improve patient outcomes. Repetitive transcranial magnetic stimulation (rTMS), a safe form of non-invasive brain stimulation, can use magnetic fields in a specific area of the brain to stimulate nerve cells. A brain region called the right superior frontal gyrus (rSFG) has been identified as an area with chemical differences in children with ADHD. We will use rTMS to target the rSFG in children with ADHD and determine if it can improve their attention abilities and if that is related to their chemical changes in the brain. Attention abilities will be determined using behavioural tests. The chemical changes in the brain will be measured using a non-invasive magnetic resonance spectroscopy (MRS) scan. Together, we expect that rTMS will alter the levels of chemicals in the rSFG and will be related to an improvement in attention abilities after the treatment. Children aged 8-15 with ADHD will be asked to participate in treatment for one hour a day, 5 days a week for 4 weeks. The participants will be randomly assigned to an active or placebo group. We hope to show that attention abilities are improved in the group that receives active treatment.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wiley, Bevin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~